Literature DB >> 6527833

Dermorphin, a new peptide from amphibian skin, inhibits the nociceptive thalamic neurons firing rate evoked by noxious stimuli.

P C Braga, M Tiengo, G Biella, G Dall'Oglio, F Fraschini.   

Abstract

Dermorphin is the representative of a new class of potent opioid peptides occurring in amphibian skin and possesses the unique feature of having a D-Ala residue incorporated in the peptide molecule. The effect of dermorphin on the spontaneous and evoked neuronal activity by a nociceptive stimulus was studied in the nucleus lateralis anterior and ventrobasal complex of the rat thalamus. The high firing frequency induced by nociceptive stimuli was blocked when dermorphin was injected intraperitoneally at the dose of 1.5 mg/kg. The action starts about 10 min after injection and lasts on average for 120 min. Naloxone, a specific opioid antagonist, injected i.p. at a dose of 1 mg/kg antagonized the effect of dermorphin. The dermorphin time-course is about twice that of morphine (1.5 mg/kg i.p.) under the same experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6527833     DOI: 10.1016/0304-3940(84)90368-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor.

Authors:  F Porreca; S E Burgess; L R Gardell; T W Vanderah; T P Malan; M H Ossipov; D A Lappi; J Lai
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

Review 2.  Rediscovery of old drugs: the forgotten case of dermorphin for postoperative pain and palliation.

Authors:  Jan M Keppel Hesselink; Michael E Schatman
Journal:  J Pain Res       Date:  2018-11-23       Impact factor: 3.133

3.  The use of tritium-labeled dermorphin for studying the interactions of C-terminal dermorphin fragment Tyr-Pro-Ser-NH2 and its stereoisomer Tyr-D-Pro-Ser-NH2 with opioid receptors.

Authors:  P S Gromovykh; O Yu Sokolov; N V Kost; A A Zozulya; L S Guzevatykh; L A Andreeva; L Yu Alfeeva; K V Shevchenko; V P Shevchenko; I Yu Nagaev; N F Myasoyedov
Journal:  Dokl Biol Sci       Date:  2008 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.